Technological innovations within the sector are critical in driving the biotechnology reagents market forward, with developments in fluorescence-based assays, high-throughput screening technologies, and the production of biopharmaceuticals necessitating advanced reagents that offer higher sensitivity and specificity. The expansion of the diagnostics sector, spurred by the COVID-19 pandemic and the increasing prevalence of chronic diseases, further underscores the need for precise diagnostic reagents. Additionally, the growing trend of collaborations between academic and commercial entities to expedite the commercialization of research is enhancing the demand for sophisticated biotechnology reagents, supporting the dynamic growth of this market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Chromatography Technology segment, which is expected to reach US$40.6 Billion by 2030 with a CAGR of a 3.5%. The In-vitro Diagnostics Technology segment is also set to grow at 3.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $26.8 Billion in 2023, and China, forecasted to grow at an impressive 7.4% CAGR to reach $28.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biotechnology Reagents Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biotechnology Reagents Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biotechnology Reagents Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Molecular, Inc., Agilent Technologies, Inc., BD Biosciences, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 267 Featured):
- Abbott Molecular, Inc.
- Agilent Technologies, Inc.
- BD Biosciences
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Bio-Techne Coporation
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Fitzgerald Industries International
- General Electric Company
- Hoefer, Inc.
- Lonza Group Ltd.
- Merck KGaA
- Meridian Bioscience, Inc.
- Olympus Corporation
- Ortho Clinical Diagnostics
- PerkinElmer, Inc.
- Promega Corporation
- Quality Biological, Inc.
- Siemens Healthineers
- Sysmex Corporation
- Takara Holdings, Inc.
- Thermo Fisher Scientific, Inc.
- Tosoh Europe N.V.
- W. R. Grace & Co.
- Waters Corporation
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Molecular, Inc.
- Agilent Technologies, Inc.
- BD Biosciences
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Bio-Techne Coporation
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Fitzgerald Industries International
- General Electric Company
- Hoefer, Inc.
- Lonza Group Ltd.
- Merck KGaA
- Meridian Bioscience, Inc.
- Olympus Corporation
- Ortho Clinical Diagnostics
- PerkinElmer, Inc.
- Promega Corporation
- Quality Biological, Inc.
- Siemens Healthineers
- Sysmex Corporation
- Takara Holdings, Inc.
- Thermo Fisher Scientific, Inc.
- Tosoh Europe N.V.
- W. R. Grace & Co.
- Waters Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 232 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 99.3 Billion |
Forecasted Market Value ( USD | $ 135.1 Billion |
Compound Annual Growth Rate | 4.5% |
Regions Covered | Global |